LeMaitre Vascular: The Compounder Keeps Compounding
Source: SeekingAlpha
2026-02-27 15:01:26 ET
I last covered LeMaitre Vascular (NASDAQ:LMAT) at $81 in June 2025 , reiterating my Buy rating. Eight months later, shares are up about 35%, more than double that of the broader market. The stock jumped ~20% alone on the recent Q4 beat and raise, with 2026 guidance coming in 13% above Wall Street’s consensus. Pricing power, operating leverage, and international growth were all contributors....
Read the full article on Seeking Alpha
For further details see:
LeMaitre Vascular: The Compounder Keeps Compounding
Boston Scientific Corporation
NASDAQ: BSX
BSX Trading
0.78% G/L:
$71.965 Last:
4,360,614 Volume:
$70.32 Open:
BSX Latest News
March 08, 2026 08:24:00 pm
BSX Investors Have Opportunity to Join Boston Scientific Corporation Fraud Investigation with the Schall Law Firm
March 06, 2026 11:42:00 am
Rosen Law Firm Urges Boston Scientific Corporation (NYSE: BSX) Stockholders to Contact the Firm for Information About Their Rights
BSX Stock Data
$110,308,512,122
1,467,617,619
0.01%
911
N/A
Medical Equipment & Supplies
Healthcare
US
Marlborough
